Tag

Ind-Swift Laboratories Limited

2 articles

Ind-Swift Labs Preferential 70 Lakh Warrant Issue

Board approved preferential issue of up to 70 lakh fully convertible warrants to promoter group entity Essix Biosciences for ₹137.20 crore. Warrants convertible into equity shares within 18 months at

Ind-Swift Laboratories Board to Consider Fundraising

Board meeting scheduled for July 10, 2026 to consider fundraising via equity/convertible securities issuance. Potential fundraising methods include preferential issue, rights issue, QIP, or other suit